J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutirrez-Ramos as New Board Member to Accelerate Global Expansion and Life Sciences R&D Growth | PR Newswire [Video]

• Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets
• He brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugs
• The appointment strengthens the company’s commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics’ mission of changing the future of healthcare

, /PRNewswire/ — Genomics, a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramosto its Board. The appointment will support the company’s rapid growth and strengthen its commercial offering globally, with a focus on scaling its life …